SAN DIEGO, CA – The San Diego Padres organization has announced a revolutionary new approach to team management, effectively transforming the Major League Baseball restricted list into a strategic financial instrument. The move, which saw star pitcher Yu Darvish placed on the list for the entire 2026 season due to elbow surgery, is being lauded internally as a masterstroke in payroll optimization.

“We’re not just building a team; we’re building a financial ecosystem,” stated Padres CEO Erik Greupner, polishing an invisible trophy. “Why pay a player to perform when you can pay them to… not perform, but still be technically on the payroll, freeing up capital for other non-playing assets? It’s genius, really. We anticipate a future where our restricted list is more competitive than our active roster.”

Sources close to the team indicate that the Padres are now actively scouting players with pre-existing, career-ending injuries, viewing them as high-value, low-risk investments for future restricted list placements. “Imagine a roster where every player is a potential financial windfall,” gushed General Manager A.J. Preller, reportedly reviewing MRI scans with the fervor of a prospect scout. “The possibilities for salary cap manipulation are endless. We could have a full lineup of guys recovering from various ailments, all contributing to our bottom line without ever stepping on the field.”

Critics argue the strategy might alienate fans who prefer to watch actual baseball, but the Padres remain undeterred. “Our fans are sophisticated,” Greupner countered. “They understand the intricate dance of modern sports finance. They’ll appreciate the fiscal prudence, even if it means fewer strikeouts and more… well, more financial reports.”

The team is reportedly exploring options to sell naming rights for their restricted list, with several pharmaceutical companies already expressing interest.